Cargando…
Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496298/ https://www.ncbi.nlm.nih.gov/pubmed/34631826 http://dx.doi.org/10.3389/fcvm.2021.724274 |
_version_ | 1784579727622668288 |
---|---|
author | Zhao, Lingyue Guo, Wenqin Huang, Weichao Wang, Lili Mo, Fanrui Chen, Xiehui Li, Chaoyang Huang, Siquan |
author_facet | Zhao, Lingyue Guo, Wenqin Huang, Weichao Wang, Lili Mo, Fanrui Chen, Xiehui Li, Chaoyang Huang, Siquan |
author_sort | Zhao, Lingyue |
collection | PubMed |
description | Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients with MVD. The PubMed and Cochrane Library databases and clinicaltrial.gov were searched for the randomized controlled trials (RCTs) comparing the FFR-guided CR, angiography-guided CR, and culprit-only revascularization (COR) strategies in STEMI patients with MVD. A Bayesian random-effect model was employed to synthesize the evidence in network meta-analysis. We used relative risk (RR) and 95% credible interval (CrI) as measures of effect size. The primary endpoint was the composite outcome of all-cause mortality or myocardial infarction (MI). Twelve RCTs were included. Angiography-guided CR showed a lower event rate of the composite outcome (RR, 0.68; 95%CrI, 0.50–0.87), all-cause mortality (RR, 0.75; 95%CrI, 0.55–0.96), MI (RR, 0.63; 95%CrI, 0.43–0.86), and repeat revascularization (RR, 0.36; 95% CrI, 0.24–0.55) compared with COR. Additionally, angiography-guided CR had a lower risk of primary outcome (RR, 0.64; 95%CrI, 0.38–0.94) and MI (RR, 0.58; 95%CrI, 0.31–0.92) than FFR-guided CR. The difference between the FFR-guided CR and COR in terms of composite outcome, all-cause mortality, and MI was similar. Angiography-guided CR was associated with the highest probability of optimal treatment for the primary outcome (98.5%), followed by FFR-guided CR (1.2%) and COR (0.3%). STEMI patients with MVD benefitted more from angiography-guided CR than from FFR-guided CR. However, only one study compared the effectiveness of FFR-guided and angiography-guided PCI; thus, the comparison between FFR-guided and angiography-guided PCI relied on indirect evidence. Therefore, further studies directly comparing the effectiveness of these two CR strategies are warranted. |
format | Online Article Text |
id | pubmed-8496298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84962982021-10-08 Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis Zhao, Lingyue Guo, Wenqin Huang, Weichao Wang, Lili Mo, Fanrui Chen, Xiehui Li, Chaoyang Huang, Siquan Front Cardiovasc Med Cardiovascular Medicine Whether fractional flow reserve (FFR) should be available for revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) is controversial. We aimed to compare the efficacy of various complete revascularization (CR) regimens for STEMI patients with MVD. The PubMed and Cochrane Library databases and clinicaltrial.gov were searched for the randomized controlled trials (RCTs) comparing the FFR-guided CR, angiography-guided CR, and culprit-only revascularization (COR) strategies in STEMI patients with MVD. A Bayesian random-effect model was employed to synthesize the evidence in network meta-analysis. We used relative risk (RR) and 95% credible interval (CrI) as measures of effect size. The primary endpoint was the composite outcome of all-cause mortality or myocardial infarction (MI). Twelve RCTs were included. Angiography-guided CR showed a lower event rate of the composite outcome (RR, 0.68; 95%CrI, 0.50–0.87), all-cause mortality (RR, 0.75; 95%CrI, 0.55–0.96), MI (RR, 0.63; 95%CrI, 0.43–0.86), and repeat revascularization (RR, 0.36; 95% CrI, 0.24–0.55) compared with COR. Additionally, angiography-guided CR had a lower risk of primary outcome (RR, 0.64; 95%CrI, 0.38–0.94) and MI (RR, 0.58; 95%CrI, 0.31–0.92) than FFR-guided CR. The difference between the FFR-guided CR and COR in terms of composite outcome, all-cause mortality, and MI was similar. Angiography-guided CR was associated with the highest probability of optimal treatment for the primary outcome (98.5%), followed by FFR-guided CR (1.2%) and COR (0.3%). STEMI patients with MVD benefitted more from angiography-guided CR than from FFR-guided CR. However, only one study compared the effectiveness of FFR-guided and angiography-guided PCI; thus, the comparison between FFR-guided and angiography-guided PCI relied on indirect evidence. Therefore, further studies directly comparing the effectiveness of these two CR strategies are warranted. Frontiers Media S.A. 2021-09-23 /pmc/articles/PMC8496298/ /pubmed/34631826 http://dx.doi.org/10.3389/fcvm.2021.724274 Text en Copyright © 2021 Zhao, Guo, Huang, Wang, Mo, Chen, Li and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Zhao, Lingyue Guo, Wenqin Huang, Weichao Wang, Lili Mo, Fanrui Chen, Xiehui Li, Chaoyang Huang, Siquan Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title | Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title_full | Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title_fullStr | Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title_full_unstemmed | Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title_short | Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis |
title_sort | comparative effectiveness of complete revascularization strategies in patients with st-segment elevation myocardial infarction and multivessel disease: a bayesian network meta-analysis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496298/ https://www.ncbi.nlm.nih.gov/pubmed/34631826 http://dx.doi.org/10.3389/fcvm.2021.724274 |
work_keys_str_mv | AT zhaolingyue comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT guowenqin comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT huangweichao comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT wanglili comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT mofanrui comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT chenxiehui comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT lichaoyang comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis AT huangsiquan comparativeeffectivenessofcompleterevascularizationstrategiesinpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseabayesiannetworkmetaanalysis |